EUVIMEDEUVIMED entdecken
Crossref

Potential side effects after first and second doses of Pfizer-BioNTech COVID-19 vaccine in the United Arabia Emirates

Balsam Qubais Saeed, Ahmed Omar Adrees, Kubais Saeed Fahady, Rula Al Shahrabi, Zainab Mansour Alkokhardi, Kholod Hussain Haj Hussain, Noor Sarchanar Jamal, Mahmood Haitham Al Awaad

Advances in Biomedical and Health Sciences · 2023

DOI: 10.4103/abhs.abhs_12_23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Biomedical and Health Sciences, 2023. Verfasst von Balsam Qubais Saeed und 7 weiteren Autor:innen. Die Arbeit nennt 24 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background: mRNA technology has been used to manufacture the Pfizer vaccine; however, the side effects of Pfizer–BioNTech coronavirus disease 2019 (COVID-19) vaccine among the general population remain unknown. The aim of this study was to investigate the potential side effects of vaccination and the associated risk factors.

Methods

A cross-sectional survey-based study was conducted from April 2021 to September 2021 using an online questionnaire to collect data on the side effects after the first and second doses of the vaccine. Participants were classified into the two following groups: Those aged ≤39 and >39 years.

Results

The most common side effects following the first dose (≤39 years vs. >39 years) were pain at the vaccination site, fatigue, severe pain at the vaccination site, and fever. Meanwhile, pain at the vaccination site, fever, fatigue, headache, muscle pain, and lethargy were the most common side effects following the second dose of vaccination in both groups. Side effects were more common in women at both doses. The most common reactions at first dose were fatigue, fever, tenderness, lethargy, and muscle pain, whereas fever, fatigue, headache, severe injection site pain, muscle pain, and lethargy were common after the second dose. None of the participants required intensive hospitalization; 4.2% of the participants in both age groups visited the clinics for minor management.

Conclusion

Pfizer–BioNTech COVID-19 vaccine was associated with a higher prevalence of local side effects in both sexes and age groups. The sex- and age-based differences warrant further rigorous investigation and standardized methodologies.

Zitieren

APA

Saeed, B. Q., Adrees, A. O., Fahady, K. S., Shahrabi, R. A., Alkokhardi, Z. M., Hussain, K. H. H., Jamal, N. S., & Awaad, M. H. A. (2023). Potential side effects after first and second doses of Pfizer-BioNTech COVID-19 vaccine in the United Arabia Emirates. Advances in Biomedical and Health Sciences. https://doi.org/10.4103/abhs.abhs_12_23

Vancouver

Saeed BQ, Adrees AO, Fahady KS, Shahrabi RA, Alkokhardi ZM, Hussain KHH, et al. Potential side effects after first and second doses of Pfizer-BioNTech COVID-19 vaccine in the United Arabia Emirates. Advances in Biomedical and Health Sciences. 2023. doi:10.4103/abhs.abhs_12_23

BibTeX
@article{Saeed2023,
  author = {Saeed, Balsam Qubais and Adrees, Ahmed Omar and Fahady, Kubais Saeed and Shahrabi, Rula Al and Alkokhardi, Zainab Mansour and Hussain, Kholod Hussain Haj and Jamal, Noor Sarchanar and Awaad, Mahmood Haitham Al},
  title = {Potential side effects after first and second doses of Pfizer-BioNTech COVID-19 vaccine in the United Arabia Emirates},
  journal = {Advances in Biomedical and Health Sciences},
  year = {2023},
  doi = {10.4103/abhs.abhs_12_23}
}
Kostenlos starten →